Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
Patients suffering from uveal melanoma (typed positive for monosomy 3 and without evidence for metastases) will be vaccinated over a period of 2 years with Dendritic Cell loaded with autologous Tumor RNA. 200 patients will be included. The Trial is an open multicenter Phase III Trial.
Epistemonikos ID: fc767965aef3d68383b6f9571309eaa62bd3c322
First added on: May 11, 2024